Archive - August 2018
MHRA clarifies post-Brexit clinical trials rules
Women’s Heart Attack Survival Chances Increase With Female Doctors, Study Finds
Janssen and Immune Bioscience team up for oncology antibodies
Regeneron and Bluebird sign $100m cell therapies deal
Almirall acquires Allergan’s dermatology portfolio for $650m
Regeneron and Bluebird Bio collaborate on T-cells in $100 million deal
Boehringer and partners set sights on cystic fibrosis gene therapy
Boehringer joins consortium to develop new cystic fibrosis gene therapies